CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 24 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $232,000 | -16.5% | 290,471 | 0.0% | 0.00% | – |
| Q2 2018 | $278,000 | +101.4% | 290,471 | +279.1% | 0.00% | – |
| Q1 2018 | $138,000 | +21.1% | 76,612 | 0.0% | 0.00% | – |
| Q4 2017 | $114,000 | +72.7% | 76,612 | +146.1% | 0.00% | – |
| Q3 2017 | $66,000 | +50.0% | 31,136 | 0.0% | 0.00% | – |
| Q2 2017 | $44,000 | -17.0% | 31,136 | -7.2% | 0.00% | – |
| Q1 2017 | $53,000 | -55.5% | 33,535 | +1.0% | 0.00% | – |
| Q4 2016 | $119,000 | -41.4% | 33,211 | +0.7% | 0.00% | – |
| Q3 2016 | $203,000 | +67.8% | 32,995 | +0.2% | 0.00% | – |
| Q2 2016 | $121,000 | -35.3% | 32,941 | -11.3% | 0.00% | – |
| Q1 2016 | $187,000 | -36.6% | 37,153 | -0.1% | 0.00% | – |
| Q4 2015 | $295,000 | +12.2% | 37,207 | +14.3% | 0.00% | – |
| Q3 2015 | $263,000 | – | 32,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $22,661,000 | 18.22% |
| Clarus Ventures, LLC | 2,752,488 | $21,827,000 | 15.30% |
| Camber Capital Management LP | 1,000,000 | $7,930,000 | 0.51% |
| Rhenman & Partners Asset Management AB | 306,227 | $2,428,000 | 0.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 643,580 | $5,104,000 | 0.21% |
| SPHERA FUNDS MANAGEMENT LTD. | 80,742 | $640,000 | 0.09% |
| Spark Investment Management LLC | 23,100 | $183,000 | 0.02% |
| FRED ALGER MANAGEMENT, LLC | 157,782 | $1,251,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 45,000 | $357,000 | 0.01% |
| FEDERATED HERMES, INC. | 80,000 | $634,000 | 0.00% |